These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15535041)

  • 1. [Effect of pazufloxacin mesilate, a new quinolone antibacterial agent, for intravenous use on QT interval].
    Fukuda H; Morita Y; Shiotani N; Mizuo M; Komae N
    Jpn J Antibiot; 2004 Aug; 57(4):404-12. PubMed ID: 15535041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
    Fukuda H; Kawamura Y
    Jpn J Antibiot; 2002 Jun; 55(3):270-80. PubMed ID: 12199111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
    Nagasawa M; Nakamura S; Miyazaki M; Nojima Y; Hayakawa H; Kawamura Y
    Jpn J Antibiot; 2002 Jun; 55(3):259-69. PubMed ID: 12199110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Attenuation of arbekacin-induced nephrotoxicity in rats by pazufloxacin mesilate].
    Kizawa K; Miyazaki M; Nagasawa M; Ogake N; Nagai A; Sanzen T; Kawamura Y
    Jpn J Antibiot; 2003 Feb; 56(1):44-54. PubMed ID: 12723398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological properties and expected clinical role of an injectable new quinolone antibiotic, pazufloxacin mesilate].
    Minami S; Hattori R; Matsuda A
    Nihon Yakurigaku Zasshi; 2003 Aug; 122(2):161-78. PubMed ID: 12890902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of pazufloxacin mesilate in Legionnaires' disease: a case report and in vitro study of the isolate.
    Higa F; Shinzato T; Toyama M; Haranaga S; Furugen M; Tateyama M; Kawakami K; Saito A
    J Infect Chemother; 2005 Jun; 11(3):164-8. PubMed ID: 15990982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of inhalation anesthetics isoflurane and sevoflurane for the drug-induced QT-interval prolongation in guinea pigs.
    Nagasawa Y; Sakai K; Kurimoto R; Kawakami S; Aimoto M; Takahara A
    J Pharmacol Sci; 2020 May; 143(1):39-44. PubMed ID: 32151542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of sequential therapy using pazufloxacin followed by oral fluoroquinolones for treatment of pyelonephritis.
    Takahashi K; Muratani T; Akasaka S; Yamada Y; Matsumoto T
    J Infect Chemother; 2013 Jun; 19(3):456-64. PubMed ID: 23188166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the fluoroquinolone antibacterial agents on the action potential duration in guinea pig ventricular myocardia.
    Hagiwara T; Satoh S; Kasai Y; Takasuna K
    Jpn J Pharmacol; 2001 Nov; 87(3):231-4. PubMed ID: 11885973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Interspecies Differences in Drug-Induced QTc Interval Prolongation in Cynomolgus Monkeys, Dogs and Humans.
    Dubois VF; de Witte WE; Visser SA; Danhof M; Della Pasqua O; ;
    Pharm Res; 2016 Jan; 33(1):40-51. PubMed ID: 26553352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of long-term oral application of quinolones on the ECG curve in dogs.
    Cepiel A; Noszczyk-Nowak A; Cekiera A; Popiel J; Pasławska U
    Pol J Vet Sci; 2017 Sep; 20(3):567-572. PubMed ID: 29166279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk.
    Lengyel C; Dézsi L; Biliczki P; Horváth C; Virág L; Iost N; Németh M; Tálosi L; Papp JG; Varró A
    Br J Pharmacol; 2004 Sep; 143(1):152-8. PubMed ID: 15302678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.
    Lu HR; Vlaminckx E; Van de Water A; Rohrbacher J; Hermans A; Gallacher DJ
    Eur J Pharmacol; 2006 Dec; 553(1-3):229-39. PubMed ID: 17054943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.
    Briasoulis A; Agarwal V; Pierce WJ
    Cardiology; 2011; 120(2):103-10. PubMed ID: 22156660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmias associated with fluoroquinolone therapy.
    Falagas ME; Rafailidis PI; Rosmarakis ES
    Int J Antimicrob Agents; 2007 Apr; 29(4):374-9. PubMed ID: 17241772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the acute cardiotoxicity of the antimalarial drug halofantrine in vitro and in vivo in anaesthetized guinea-pigs.
    Batey AJ; Lightbown ID; Lambert JP; Edwards G; Coker SJ
    Br J Pharmacol; 1997 Oct; 122(3):563-9. PubMed ID: 9351516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve.
    Vormberge T; Hoffmann M; Himmel H
    J Pharmacol Toxicol Methods; 2006; 54(2):130-40. PubMed ID: 16757186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxifloxacin-induced QT prolongation and torsades: an uncommon effect of a common drug.
    Badshah A; Janjua M; Younas F; Halabi AR; Cotant JF
    Am J Med Sci; 2009 Aug; 338(2):164-6. PubMed ID: 19680025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cefoperazone and azithromycin on the pharmacokinetics of pazufloxacin in rats.
    Lou S; Li W; Hu Q
    Eur J Drug Metab Pharmacokinet; 2007; 32(4):219-23. PubMed ID: 18348471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.